I noticed that a well-known XRP analyst named Jaidy posted an interesting analysis on the X platform. He says that the current setup on XRP might be strong enough to achieve a significant jump. The important thing here is that he sees a bullish divergence on the monthly timeframe — which he calls RSI bullish divergence — along with a strong retest of a trendline that has been extending for almost seven years.



For those who don’t know: a bullish divergence occurs when the price makes a higher low while the (RSI) indicator makes a lower low. This usually indicates underlying strength even if the market appears weak on the surface. XRP has tested this long-term trendline as strong support, which makes the combination intriguing.

The expected target? Jaidy says XRP could reach $5.32 if Bitcoin’s dominance begins to decline significantly. This would mean a market cap around $325 billion, roughly four times the current value of $85.25 billion. Currently, XRP is trading around $1.38, so there’s plenty of room for upward movement if this scenario plays out.

Interestingly, this aligns with other analysts’ predictions about the altcoin cycle. In 2017, when dominance dropped from 95% to 37%, XRP surged over 70,000%. That cycle already saw a 600% increase from $0.49 to $3.66, but dominance has not yet collapsed structurally. If that happens by 2026, we could see a strong second wave.

Of course, Jaidy also warns of an alternative scenario — what he calls the “Pink Box” or deep correction. But he emphasizes that the bullish divergence will remain valid even in that case, meaning the big opportunity might come in the next cycle rather than this one. Essentially, a winning scenario is still on the table one way or another.
XRP-0.58%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments